Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/30/2010US20100251401 Plants and seeds of corn variety cv374246
09/30/2010US20100251400 Plants and seeds of corn variety cv729740
09/30/2010US20100251399 Plants and seeds of corn variety cv468110
09/30/2010US20100251398 Plants and seeds of corn variety cv585594
09/30/2010US20100251396 Transgenic mice expressing human formyl peptide receptor
09/30/2010US20100251395 Using cytosine deaminases to diminish retroelement transfer from pigs to humans
09/30/2010US20100251393 Transgenic animals
09/30/2010US20100251392 Methods for assessing the delivery of exogenous agents
09/30/2010US20100249377 ENGINEERED HYBIRD PHAGE VECTORS FOR THE DESIGN AND THE GENERATION OF A HUMAN NON-ANTIBODY PEPTIDE OR PROTEIN PHAGE LIBRARY VIA FUSION TO pIX OF M13 PHAGE
09/30/2010US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
09/30/2010US20100249372 Botulinum neurotoxin a receptor and the use thereof
09/30/2010US20100249221 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
09/30/2010US20100249220 Coumermycin/novobicin-regulated gene expression system
09/30/2010US20100249219 Short rna antagonist compounds for the modulation of hif-1alpha
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249217 Modulators of pharmacological agents
09/30/2010US20100249216 Method for the production of a cell and/or tissue and/or disease phase specific medicament
09/30/2010US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs
09/30/2010US20100249214 Multiplex dicer substrate rna interference molecules having joining sequences
09/30/2010US20100249212 Gene Silencing Using mRNA-cDNA Hybrids
09/30/2010US20100249208 Novel Methods and Models for Rapid, Widespread Delivery of Genetic Material to the CNS Using Non-Viral, Cationic Lipid-Mediated Vectors
09/30/2010US20100249052 Dsrna compositions and methods for treating hpv infections
09/30/2010US20100249034 Gfralpha3 and its uses
09/30/2010US20100249029 Peptides with high affinity for the prolactin receptor
09/30/2010US20100249026 Albumin fusion proteins
09/30/2010US20100249021 Method and medicament for inhibiting the infection of influenza virus
09/30/2010US20100249015 Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
09/30/2010US20100248989 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
09/30/2010US20100248972 Enhanced Expression Method
09/30/2010US20100248373 Method for introducing foreign substance into cell having cell wall
09/30/2010US20100248371 Methods and compositions for modulating rad51 and homologous recombination
09/30/2010US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners
09/30/2010US20100248359 Anti-Glypican 3 Antibody
09/30/2010US20100248357 Nematode Fatty Acid Desaturase-Like Sequences
09/30/2010US20100248356 hTERT GENE EXPRESSION REGULATORY GENE
09/30/2010US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/30/2010US20100248336 Methods for purifying nucleic acids
09/30/2010US20100248319 Ethanol Production
09/30/2010US20100248312 Alanine 2,3-aminomutases and related polynucleotides
09/30/2010US20100248309 Thermostable alpha1-antitrypsin mutein with a disulfide bond and the method for preparing it
09/30/2010US20100248308 Recombinant Microorganism and a Method for Producing Poly-Gamma-Glutamic Acid
09/30/2010US20100248305 Polyamino acid synthetase and gene encoding the same
09/30/2010US20100248304 Dual expression vector system and screening methods
09/30/2010US20100248267 Method for measurement of concentration of antigen
09/30/2010US20100248255 Novel peptides
09/30/2010US20100248241 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
09/30/2010US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof
09/30/2010US20100248233 Acetyl-coa producing enzymes in yeast
09/30/2010US20100248232 Methods for determining the presence or absence of elite event ms-bn1 in brassica plant material
09/30/2010US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions
09/30/2010US20100247733 Plants and seeds of corn variety cv006790
09/30/2010US20100247662 Biologic Modulations with Nanoparticles
09/30/2010US20100247657 Telomerase reverse transcriptase variant
09/30/2010US20100247624 Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
09/30/2010US20100247621 Codon modified immunogenic compositions and methods of use
09/30/2010US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof
09/30/2010US20100247576 Nucleotide and amino acid sequences encoding an exported protein 1 derived from plasmodium vivax and uses thereof
09/30/2010US20100247572 Viruses encoding mutant membrane protein
09/30/2010US20100247570 High Mannose Glycoprotein Epitopes
09/30/2010US20100247565 Chimeric sindbis-eastern equine encephalitis virus and uses thereof
09/30/2010US20100247561 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/30/2010US20100247560 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof
09/30/2010US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE
09/30/2010US20100247553 Goodpasture Antigen Binding Protein
09/30/2010US20100247549 Monoclonal antibodies against dengue and other viruses with deletion in fc region
09/30/2010US20100247546 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/30/2010US20100247545 Antibodies to m-csf
09/30/2010US20100247542 Truncated variant of the mammalian target for rapamycin (mtor) protein
09/30/2010US20100247531 Anti-fgfr3 antibodies and methods using same
09/30/2010US20100247530 Compositions and methods for preventing and treating presbycusis
09/30/2010US20100247523 Subtypes of humanized antibody against interleuken-6 receptor
09/30/2010US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247509 Fusion Proteins
09/30/2010US20100247497 Vector particles for targetng cd34+ cells
09/30/2010US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38
09/30/2010US20100247486 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same
09/30/2010US20100247442 Macaca fascicularis ST2L
09/30/2010US20100242358 Hypersensitive response induced resistance in plants by seed treatment
09/30/2010DE102009014432A1 New nucleic acid, having gene cluster for synthesis of caprazamycin and comprising a fully defined base pair sequence, useful for biosynthesis of caprazamycin that is useful as antibiotic against gram positive bacteria e.g. Mycobacterium
09/30/2010DE102009014431A1 New aromatic prenyltransferase comprising a specific amino acid sequence or its conservative variation, useful e.g. as a biocatalyst for the production of prenylated aromatic compounds, preferably prenylated phenazine derivatives
09/30/2010CA2756752A1 Improved type milk-clotting protease derived from a microorganism
09/30/2010CA2756750A1 A method for producing bicyclic .gamma.-amino acid derivative
09/30/2010CA2756670A1 Mesenchymal stem cells producing inhibitory rna for disease modification
09/30/2010CA2756596A1 Methods and compositions for the treatment of cirrhosis and liver fibrosis
09/30/2010CA2756569A1 Markers related to age-related macular degeneration and uses therefor
09/30/2010CA2756412A1 Compositions for stimulation of mammalian innate immune resistance to pathogens
09/30/2010CA2756197A1 Factor viii variants and methods of use
09/30/2010CA2756168A1 Isoform nell-1 peptide
09/30/2010CA2756070A1 Kanamycin antisense nucleic acid for the treatment of cancer
09/30/2010CA2756069A1 Rna interference mediated inhibition of the intercellular adhesion molecule 1 (icam-1)gene expression using short interfering nucleic acid (sina)
09/30/2010CA2756034A1 Process for the production of transgenic plants that have a high content and yield of starch and biomass
09/30/2010CA2755983A1 Compounds and methods for modulating an immune response
09/30/2010CA2755799A1 Method and apparatus for predicting susceptibility to a developmental disorder
09/30/2010CA2755387A1 Novel lysophospholipid acyltransferase
09/30/2010CA2754949A1 Method for producing high amount of glycolic acid by fermentation
09/30/2010CA2754916A1 Transgenic plants with altered redox mechanisms and increased yield
09/30/2010CA2753988A1 Novel anti-.alpha.5.beta.1 antibodies and uses thereof
09/30/2010CA2753874A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding snf2 domain-containing polypeptides
09/30/2010CA2752007A1 Polypeptides having acetyl xylan esterase activity and polynucleotides encoding same
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 4023